Global Retinal Biosimilars Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 115 pages | ID: G54B1279A6AGEN
GlobalInfoResearch

Abstracts

SCOPE OF THE REPORT:

The global Retinal Biosimilars market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Retinal Biosimilars.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Retinal Biosimilars market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Retinal Biosimilars market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Novartis (Sandoz)
• Shire
• Bayer
• Genentech
• Pfenex
• Reliance Life Sciences
• Hetero Drugs
• Intas Pharmaceuticals
• Santo Holding
• Regeneron Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Macular Degeneration Drugs
• Diabetic Eye Disease Drugs
• Macular Pucker Drugs
• Others

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

1 RETINAL BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Retinal Biosimilars
1.2 Classification of Retinal Biosimilars by Types
  1.2.1 Global Retinal Biosimilars Revenue Comparison by Types (2017-2023)
  1.2.2 Global Retinal Biosimilars Revenue Market Share by Types in 2017
  1.2.3 Macular Degeneration Drugs
  1.2.4 Diabetic Eye Disease Drugs
  1.2.5 Macular Pucker Drugs
  1.2.6 Others
1.3 Global Retinal Biosimilars Market by Application
  1.3.1 Global Retinal Biosimilars Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Retinal Biosimilars Market by Regions
  1.4.1 Global Retinal Biosimilars Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Retinal Biosimilars Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Retinal Biosimilars Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinal Biosimilars Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Retinal Biosimilars Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinal Biosimilars Status and Prospect (2013-2023)
1.5 Global Market Size of Retinal Biosimilars (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis (Sandoz)
  2.1.1 Business Overview
  2.1.2 Retinal Biosimilars Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis (Sandoz) Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.2 Shire
  2.2.1 Business Overview
  2.2.2 Retinal Biosimilars Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Shire Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
  2.3.1 Business Overview
  2.3.2 Retinal Biosimilars Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bayer Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.4 Genentech
  2.4.1 Business Overview
  2.4.2 Retinal Biosimilars Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Genentech Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfenex
  2.5.1 Business Overview
  2.5.2 Retinal Biosimilars Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Pfenex Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.6 Reliance Life Sciences
  2.6.1 Business Overview
  2.6.2 Retinal Biosimilars Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Reliance Life Sciences Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hetero Drugs
  2.7.1 Business Overview
  2.7.2 Retinal Biosimilars Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Hetero Drugs Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.8 Intas Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Retinal Biosimilars Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Intas Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.9 Santo Holding
  2.9.1 Business Overview
  2.9.2 Retinal Biosimilars Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Santo Holding Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
2.10 Regeneron Pharmaceuticals
  2.10.1 Business Overview
  2.10.2 Retinal Biosimilars Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Regeneron Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL RETINAL BIOSIMILARS MARKET COMPETITION, BY PLAYERS

3.1 Global Retinal Biosimilars Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Retinal Biosimilars Players Market Share
  3.2.2 Top 10 Retinal Biosimilars Players Market Share
3.3 Market Competition Trend

4 GLOBAL RETINAL BIOSIMILARS MARKET SIZE BY REGIONS

4.1 Global Retinal Biosimilars Revenue and Market Share by Regions
4.2 North America Retinal Biosimilars Revenue and Growth Rate (2013-2018)
4.3 Europe Retinal Biosimilars Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2013-2018)
4.5 South America Retinal Biosimilars Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Retinal Biosimilars Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA RETINAL BIOSIMILARS REVENUE BY COUNTRIES

5.1 North America Retinal Biosimilars Revenue by Countries (2013-2018)
5.2 USA Retinal Biosimilars Revenue and Growth Rate (2013-2018)
5.3 Canada Retinal Biosimilars Revenue and Growth Rate (2013-2018)
5.4 Mexico Retinal Biosimilars Revenue and Growth Rate (2013-2018)

6 EUROPE RETINAL BIOSIMILARS REVENUE BY COUNTRIES

6.1 Europe Retinal Biosimilars Revenue by Countries (2013-2018)
6.2 Germany Retinal Biosimilars Revenue and Growth Rate (2013-2018)
6.3 UK Retinal Biosimilars Revenue and Growth Rate (2013-2018)
6.4 France Retinal Biosimilars Revenue and Growth Rate (2013-2018)
6.5 Russia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
6.6 Italy Retinal Biosimilars Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC RETINAL BIOSIMILARS REVENUE BY COUNTRIES

7.1 Asia-Pacific Retinal Biosimilars Revenue by Countries (2013-2018)
7.2 China Retinal Biosimilars Revenue and Growth Rate (2013-2018)
7.3 Japan Retinal Biosimilars Revenue and Growth Rate (2013-2018)
7.4 Korea Retinal Biosimilars Revenue and Growth Rate (2013-2018)
7.5 India Retinal Biosimilars Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Retinal Biosimilars Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA RETINAL BIOSIMILARS REVENUE BY COUNTRIES

8.1 South America Retinal Biosimilars Revenue by Countries (2013-2018)
8.2 Brazil Retinal Biosimilars Revenue and Growth Rate (2013-2018)
8.3 Argentina Retinal Biosimilars Revenue and Growth Rate (2013-2018)
8.4 Colombia Retinal Biosimilars Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE RETINAL BIOSIMILARS BY COUNTRIES

9.1 Middle East and Africa Retinal Biosimilars Revenue by Countries (2013-2018)
9.2 Saudi Arabia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
9.3 UAE Retinal Biosimilars Revenue and Growth Rate (2013-2018)
9.4 Egypt Retinal Biosimilars Revenue and Growth Rate (2013-2018)
9.5 Nigeria Retinal Biosimilars Revenue and Growth Rate (2013-2018)
9.6 South Africa Retinal Biosimilars Revenue and Growth Rate (2013-2018)

10 GLOBAL RETINAL BIOSIMILARS MARKET SEGMENT BY TYPE

10.1 Global Retinal Biosimilars Revenue and Market Share by Type (2013-2018)
10.2 Global Retinal Biosimilars Market Forecast by Type (2018-2023)
10.3 Macular Degeneration Drugs Revenue Growth Rate (2013-2023)
10.4 Diabetic Eye Disease Drugs Revenue Growth Rate (2013-2023)
10.5 Macular Pucker Drugs Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL RETINAL BIOSIMILARS MARKET SEGMENT BY APPLICATION

11.1 Global Retinal Biosimilars Revenue Market Share by Application (2013-2018)
11.2 Retinal Biosimilars Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL RETINAL BIOSIMILARS MARKET SIZE FORECAST (2018-2023)

12.1 Global Retinal Biosimilars Market Size Forecast (2018-2023)
12.2 Global Retinal Biosimilars Market Forecast by Regions (2018-2023)
12.3 North America Retinal Biosimilars Revenue Market Forecast (2018-2023)
12.4 Europe Retinal Biosimilars Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Retinal Biosimilars Revenue Market Forecast (2018-2023)
12.6 South America Retinal Biosimilars Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Retinal Biosimilars Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Retinal Biosimilars Picture
Table Product Specifications of Retinal Biosimilars
Table Global Retinal Biosimilars and Revenue (Million USD) Market Split by Product Type
Figure Global Retinal Biosimilars Revenue Market Share by Types in 2017
Figure Macular Degeneration Drugs Picture
Figure Diabetic Eye Disease Drugs Picture
Figure Macular Pucker Drugs Picture
Figure Others Picture
Table Global Retinal Biosimilars Revenue (Million USD) by Application (2013-2023)
Figure Retinal Biosimilars Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Retinal Biosimilars Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Retinal Biosimilars Revenue (Million USD) and Growth Rate (2013-2023)
Table Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table Novartis (Sandoz) Retinal Biosimilars Type and Applications
Table Novartis (Sandoz) Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Retinal Biosimilars Type and Applications
Table Shire Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Retinal Biosimilars Type and Applications
Table Bayer Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Retinal Biosimilars Type and Applications
Table Genentech Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Pfenex Basic Information, Manufacturing Base and Competitors
Table Pfenex Retinal Biosimilars Type and Applications
Table Pfenex Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table Reliance Life Sciences Retinal Biosimilars Type and Applications
Table Reliance Life Sciences Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Retinal Biosimilars Type and Applications
Table Hetero Drugs Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Retinal Biosimilars Type and Applications
Table Intas Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Santo Holding Basic Information, Manufacturing Base and Competitors
Table Santo Holding Retinal Biosimilars Type and Applications
Table Santo Holding Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Retinal Biosimilars Type and Applications
Table Regeneron Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2016-2017)
Table Global Retinal Biosimilars Revenue (Million USD) by Players (2013-2018)
Table Global Retinal Biosimilars Revenue Share by Players (2013-2018)
Figure Global Retinal Biosimilars Revenue Share by Players in 2016
Figure Global Retinal Biosimilars Revenue Share by Players in 2017
Figure Global Top 5 Players Retinal Biosimilars Revenue Market Share in 2017
Figure Global Top 10 Players Retinal Biosimilars Revenue Market Share in 2017
Figure Global Retinal Biosimilars Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Retinal Biosimilars Revenue (Million USD) by Regions (2013-2018)
Table Global Retinal Biosimilars Revenue Market Share by Regions (2013-2018)
Figure Global Retinal Biosimilars Revenue Market Share by Regions (2013-2018)
Figure Global Retinal Biosimilars Revenue Market Share by Regions in 2017
Figure North America Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Europe Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure South America Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table North America Retinal Biosimilars Revenue by Countries (2013-2018)
Table North America Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure North America Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure North America Retinal Biosimilars Revenue Market Share by Countries in 2017
Figure USA Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Canada Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Mexico Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table Europe Retinal Biosimilars Revenue (Million USD) by Countries (2013-2018)
Figure Europe Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Europe Retinal Biosimilars Revenue Market Share by Countries in 2017
Figure Germany Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure UK Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure France Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Russia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Italy Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Retinal Biosimilars Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Retinal Biosimilars Revenue Market Share by Countries in 2017
Figure China Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Japan Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Korea Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure India Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table South America Retinal Biosimilars Revenue by Countries (2013-2018)
Table South America Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure South America Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure South America Retinal Biosimilars Revenue Market Share by Countries in 2017
Figure Brazil Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Argentina Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Colombia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Retinal Biosimilars Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries in 2017
Figure Saudi Arabia Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure UAE Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Egypt Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure Nigeria Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Figure South Africa Retinal Biosimilars Revenue and Growth Rate (2013-2018)
Table Global Retinal Biosimilars Revenue (Million USD) by Type (2013-2018)
Table Global Retinal Biosimilars Revenue Share by Type (2013-2018)
Figure Global Retinal Biosimilars Revenue Share by Type (2013-2018)
Figure Global Retinal Biosimilars Revenue Share by Type in 2017
Table Global Retinal Biosimilars Revenue Forecast by Type (2018-2023)
Figure Global Retinal Biosimilars Market Share Forecast by Type (2018-2023)
Figure Global Macular Degeneration Drugs Revenue Growth Rate (2013-2018)
Figure Global Diabetic Eye Disease Drugs Revenue Growth Rate (2013-2018)
Figure Global Macular Pucker Drugs Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Retinal Biosimilars Revenue by Application (2013-2018)
Table Global Retinal Biosimilars Revenue Share by Application (2013-2018)
Figure Global Retinal Biosimilars Revenue Share by Application (2013-2018)
Figure Global Retinal Biosimilars Revenue Share by Application in 2017
Table Global Retinal Biosimilars Revenue Forecast by Application (2018-2023)
Figure Global Retinal Biosimilars Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retinal Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Retinal Biosimilars Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Retinal Biosimilars Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Retinal Biosimilars Revenue Market Forecast (2018-2023)
Figure Europe Retinal Biosimilars Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Retinal Biosimilars Revenue Market Forecast (2018-2023)
Figure South America Retinal Biosimilars Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Retinal Biosimilars Revenue Market Forecast (2018-2023)